VKTX

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, dedicated to developing innovative therapies for metabolic and endocrine disorders. With a focus on addressing pressing unmet medical needs, including obesity and liver disease, the company's promising pipeline features novel drug candidates poised to transform patient care. Leveraging proprietary drug development platforms and deep expertise in metabolic pathways, Viking Therapeutics aims to significantly enhance patient outcomes and establish a strong presence in the biopharmaceutical industry as it advances through clinical trials.